MedTrace Logo

Community-associated Highly-Resistant Enterobacterales

NCT03924934 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2172

Last updated 2025-05-29

No results posted yet for this study

Summary

This is a prospective multi-center study. Bacterial isolates from hospitalized patients with CA-HRE will be compared to those from hospitalized patients with healthcare-associated HRE (HA-HRE). In addition, community spread of CRE will be determined.

Conditions

  • Enterobacteriaceae Infections
  • Community-Acquired Infections
  • Healthcare Associated Infection
  • Carbapenem-Resistant Enterobacteriaceae Infection

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • David van Duin, MD, PhD · University of North Carolina, Chapel Hill

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2024-12-01
Completion
2024-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03924934 on ClinicalTrials.gov